Eyetube

Anti-VEGF, A Biography: Part 3

DME Outcomes Following TREX

David Brown, MD

Anti-VEGF with Targeted PRP

David M. Brown, MD, Jonathan L. Prenner, MD

Phase 2/3 Data for High-Dose Aflibercept for DME

David M. Brown, MD

ARVO Meeting Coverage Day 3: CANDELA and ARCHWAY Data

David Brown, MD and Robert Mittra, MD

Anti-VEGF, A Biography: Part 3

John D. Pitcher III, MD; Bob Avery, MD; David Brown, MD; Jeffrey Heier, MD; Nancy Holekamp, MD; Kirk Packo, MD; Phillip Rosenfeld, MD, PhD; and Bob Vitti, MD

The State of Biosimilars: Integration of Biosimilars into a Retina Practice

John W. Kitchens, MD (Moderator); David Brown, MD; and Kristin Yockus

Contributor:

David M. Brown, MD